Stage-specific survival differences between colon cancer subsites: a population-based study

Reima, Heigo; Soplepmann, Jaan; Innos, Kaire

doi:10.1080/0284186x.2021.1987515

Cited by 2 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…25 The geographical comparisons of our study were limited by its relatively small sample size which did not allow for separate analysis of colon and rectal cancer, and by the lack of data regarding major prognostic factors acting at initial diagnosis or after recurrence, such as surgery modalities, post relapse treatments, performance status or comorbidities. 26 Furthermore, in countries with regional registry coverage, the registry areas included in our study might differ from nationwide data in terms of health resources and organization of oncological care. The overall net survival estimations may differ from that of low resolution (i.e.…”

Section: Discussionmentioning

confidence: 99%

Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries

Bouvier,

Jooste,

Lillini

et al. 2024

Intl Journal of Cancer

Self Cite

View full text Add to dashboard Cite

Recurrence after colorectal cancer resection is rarely documented in the general population while a key clinical determinant for patient survival. We identified 8785 patients with colorectal cancer diagnosed between 2010 and 2013 and clinically followed up to 2020 in 15 cancer registries from seven European countries (Bulgaria, Switzerland, Germany, Estonia, France, Italy, and Spain). We estimated world age‐standardized net survival using a flexible cumulative excess hazard model. Recurrence rates were calculated for patients with initially resected stage I, II, or III cancer in six countries, using the actuarial survival method. The proportion of nonmetastatic resected colorectal cancers varied from 58.6% to 78.5% according to countries. The overall 5‐year net survival by country ranged between 60.8% and 74.5%. The absolute difference between the 5‐year survival extremes was 12.8 points for stage II (Bulgaria vs Switzerland), 19.7 points for stage III (Bulgaria vs. Switzerland) and 14.8 points for Stage IV and unresected cases (Bulgaria vs. Switzerland or France). Five‐year cumulative rate of recurrence among resected patients with stage I–III was 17.7%. As compared to the mean of the whole cohort, the risk of developing a recurrence did not differ between countries except a lower risk in Italy for both stage I/II and stage III cancers and a higher risk in Spain for stage III. Survival after colorectal cancer differed across the concerned European countries while there were slight differences in recurrence rates. Population‐based collection of cancer recurrence information is crucial to enhance efforts for evidence‐based management of colorectal cancer follow up.

show abstract

Section: Discussionmentioning

confidence: 99%

Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries

Bouvier,

Jooste,

Lillini

et al. 2024

Intl Journal of Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…There are many studies in the literature on patients with colorectal cancer. Most of these are clinical studies [ 3 – 8 ] study cancer treatments effects on quality of life [ 9 – 12 ], their costs [ 13 , 14 ] or both parameters simultaneously [ 15 , 16 ]. However, studies were mostly carried out on subjects such as comparison of institutions, pre-op and post-op results, and chemotherapy drug effects.…”

Section: Introductionmentioning

confidence: 99%

Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs

Erişen

Yılmaz

2023

Qual Life Res

View full text Add to dashboard Cite

Stage-specific survival differences between colon cancer subsites: a population-based study

Cited by 2 publications

References 15 publications

Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries

Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries

Comparison of chemotherapy treatment administration via venous port and peripheral vascular access in terms of quality of life and costs

Contact Info

Product

Resources

About